Compare The Coca-Cola Co K (KO) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
The Coca-Cola Co K vs Vaxcyte Inc. Common Stock — how do they compare? The Coca-Cola Co K trades at $92.29 (market cap $387.70B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: The Coca-Cola Co K is far larger — about 36.9× Vaxcyte Inc. Common Stock's market cap, and The Coca-Cola Co K pays a 2.35% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold The Coca-Cola Co K for 154 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| KO | PCVX | |
|---|---|---|
Market Cap | $387.70B | $10.51B |
Volume | 15,313,783 | 2,644,694 |
Sector | Consumer Staples | Health |
52-Week High | $91.99 | $73.82 |
52-Week Low | $67.08 | $40.32 |
Typical Hold Time | 154 Days | 0 Days |
Enterprise Value | $414.87B | $9.14B |
Dividend Yield | 2.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $91.78, up 2.22% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $95.75. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding expectations, and maintains robust profitability with a 28.56% net income margin. Recent news highlights institutional buying and stable demand trends, though RSI levels indicate potential near-term overbought conditions.
The stock offers a solid dividend profile with 64 consecutive years of increases, but faces risks from regional demand divergence and high valuation multiples. Upside is supported by earnings momentum and institutional accumulation, while macroeconomic pressures and elevated P/E of 27.06 pose caution. The balance between growth execution and market sentiment will drive near-term performance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
